Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 14, 2022; 10(2): 426-436
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.426
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.426
Table 3 The relationship between duration, dose of methylprednisolone uses and CT improvement in the corticosteroid group (mean ± SD)
| Indicator | Non-obvious absorption group (n = 4) | Obvious absorption group (n = 34) | t value | P value |
| Duration of methylprednisolone use (d) | 6.0 ± 2.0 | 6.44 ± 1.86 | -0.445 | 0.659 |
| Total methylprednisolone dose (mg) | 210.0 ± 66.33 | 239.15 ± 86.09 | -0.652 | 0.519 |
| Daily methylprednisolone dose (mg) | 35.72 ± 4.95 | 38.55 ± 13.17 | -0.422 | 0.676 |
- Citation: Lin L, Xue D, Chen JH, Wei QY, Huang ZH. Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China. World J Clin Cases 2022; 10(2): 426-436
- URL: https://www.wjgnet.com/2307-8960/full/v10/i2/426.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.426